A retrospective study in clinical course of Heicobacter pylori eradication therapy

A retrospective study in clinical course of Heicobacter pylori eradication therapy - H. pylori eradication therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032351

Enrollment

427

Registered

2018-04-25

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H.pylori infected patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who received eradication therapy(vonoprazan, PPI)

Exclusion criteria

Exclusion criteria: patient who refused the therapy

Design outcomes

Primary

Measure	Time frame
Primary outcome is non-inferiority of vonoprazan-based therapy for other regimens including PPI-based therapy.	—

Countries

Japan

Contacts

Public ContactHiroki Tanabe

International University of Health and Welfare Hospital Department of Gastroenterology

tant@asahikawa-med.ac.jp+81-287393060

Outcome results